Dr. David Spigel from Sarah Cannon Cancer Center offers his perspective on the agents he feels most likely to become clinical tools against lung cancer over the next few years.
[powerpress]
Logo
You are here
Dr. David Spigel: What are the most promising targeted therapy approaches in lung cancer for the next few years?
Related Content
Article
From the Grace Archives | Originally Published January 9, 2011 | By Dr West I just finished reading what I’d consider to be the mo
Article
From the Grace Archives | Originally Published May 30, 2011 | By Dr West | 3 Comments
Article
From the Grace Archives | Originally published March 28, 2011 | By Dr Ramchandran | 5 Comments